Bruker Corp Q1 2023 Earnings Call Summary - Thomson StreetEvents

Bruker Corp Q1 2023 Earnings Call Summary

Bruker Corp Q1 2023 Earnings Call Summary - Thomson StreetEvents
Bruker Corp Q1 2023 Earnings Call Summary
Published May 04, 2023
18 pages (10038 words) — Published May 04, 2023
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of BRKR.OQ earnings conference call or presentation 4-May-23 12:30pm GMT

  
Brief Excerpt:

...A. We are advancing our Project Accelerate 2.0 high-growth, high-margin initiatives with particular focus on the large opportunities in proteomics and spatial biology while also investing in operational excellence, productivity and our growth capacity for the next 10 years. B. In the first quarter, Bruker posted strong organic revenue growth of 17.6%. C. The robust demand for our differentiated high-value scientific instruments and life science solutions was relatively broad-based across the portfolio and bookings and backlog for Bruker have remained strong. D. For the first quarter of 2023, Bruker's revenues increased 15.2% year-over-year to $685.3 million, despite a currency headwind of minus 4.5%. E. On an organic basis, revenues increased 17.6% and acquisitions added 2.1% to growth, which implies first quarter constant exchange rate growth of 19.7% year-over-year. F. This included 18.4% organic growth in our Scientific Instruments segment and 9.7% organic growth in our BEST segment...

  
Report Type:

Brief

Source:
Thomson StreetEvents
Company:
Bruker Corp
Ticker
BRKR.OQ
Time
12:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Rachel Marie Vatnsdal Olson - JPMorgan Chase & Co, Research Division - Analyst : So a lot of talk here about China and some of the outpaced strength in 1Q. Can you just tell us what was the actual growth in China during this quarter? And then I wanted to dig into some of those earlier comments around the China stimulus package. Can you characterize a bit further around some of that pull forward versus new wind dynamics that you flagged? How much of the China performance was really driven by that pull-forward dynamic that you mentioned?

Question: Rachel Marie Vatnsdal Olson - JPMorgan Chase & Co, Research Division - Analyst : Great. And then next one for me is just on supply chain. So can you walk us through what specific segments you're seeing the most supply chain constraints still? And then what's your level of visibility for when you expect those constraints to really ease? And then follow-up to that. Is supply chain really becoming the limiting factor in terms of guidance for the rest of the year? And how much does that really play into the decision to not lift the guidance further versus some of that prudence around the macro backdrop that you flagged?

Table Of Contents

Bruker Corp To Host Investor Day Summary – 2023-06-15 – US$ 54.00 – Edited Brief of BRKR.OQ corporate analyst meeting</ 15-Jun-23 3:00pm GMT

Bruker Corp To Host Investor Day Transcript – 2023-06-15 – US$ 54.00 – Edited Transcript of BRKR.OQ corporate analyst meeting</ 15-Jun-23 3:00pm GMT

Bruker Corp at Jefferies Healthcare Conference Summary – 2023-06-09 – US$ 54.00 – Edited Brief of BRKR.OQ presentation 9-Jun-23 1:00pm GMT

Bruker Corp at Jefferies Healthcare Conference Transcript – 2023-06-09 – US$ 54.00 – Edited Transcript of BRKR.OQ presentation 9-Jun-23 1:00pm GMT

Bruker Corp Q1 2023 Earnings Call Transcript – 2023-05-04 – US$ 54.00 – Edited Transcript of BRKR.OQ earnings conference call or presentation 4-May-23 12:30pm GMT

Bruker Corp at Cowen Health Care Conference Transcript – 2023-03-06 – US$ 54.00 – Edited Transcript of BRKR.OQ presentation 6-Mar-23 7:10pm GMT

Bruker Corp at Citi Healthcare & Medtech Conference Transcript – 2023-03-02 – US$ 54.00 – Edited Transcript of BRKR.OQ presentation 2-Mar-23 2:30pm GMT

Bruker Corp Q4 2022 Earnings Call Summary – 2023-02-09 – US$ 54.00 – Edited Brief of BRKR.OQ earnings conference call or presentation 9-Feb-23 1:30pm GMT

Bruker Corp Q4 2022 Earnings Call Transcript – 2023-02-09 – US$ 54.00 – Edited Transcript of BRKR.OQ earnings conference call or presentation 9-Feb-23 1:30pm GMT

Bruker Corp at JPMorgan Healthcare Conference Transcript – 2023-01-09 – US$ 54.00 – Edited Transcript of BRKR.OQ presentation 9-Jan-23 3:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Bruker Corp Q1 2023 Earnings Call Summary" May 04, 2023. Alacra Store. May 18, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2023-Bruker-Corp-Earnings-Call-B15563189>
  
APA:
Thomson StreetEvents. (2023). Bruker Corp Q1 2023 Earnings Call Summary May 04, 2023. New York, NY: Alacra Store. Retrieved May 18, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q1-2023-Bruker-Corp-Earnings-Call-B15563189>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.